Ensifentrine Added on to Dual Bronchodilator or Triple Therapy Demonstrates Clinically Meaningful Improvement in CAT Score in Symptomatic Patients with Chronic Obstructive Pulmonary Disease

Authors

Institutions

Publication Details

Journal
International Journal of COPD
Published
2026-02-01
DOI
https://doi.org/10.2147/copd.s589655
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ensifentrine Added on to Dual Bronchodilator or Triple Therapy Demonstrates Clinically Meaningful Improvement in CAT Score in Symptomatic Patients with Chronic Obstructive Pulmonary Disease

Thomas B. Siler, Daniel Reyner, Margot MacDonald-Berko, John D. Davidson et al.
International Journal of COPD
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Ensifentrine Added on to Dual Bronchodilator or Triple Therapy Demonstrates Clinically Meaningful Improvement in CAT Score in Symptomatic Patients with Chronic Obstructive Pulmonary Disease

Thomas B. Siler, Daniel Reyner, Margot MacDonald-Berko, John D. Davidson, Kathleen Rickard, Tara Rheault
article en

Abstract

No abstract available for this paper.
International Journal of COPDVol. Volume 21
Merck & Co., Inc., Rahway, NJ, USA (United States) (US), DM-STAT (United States) (US), Lindenwood University (US)
Good health and well-being
Openalex Percentile: Top 63%
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.